Novartis AG Retained Earnings (Accumulated Deficit) 2010-2024 | NVS
Novartis AG retained earnings (accumulated deficit) for the quarter ending June 30, 2024 were $40.965B, a 19.77% decline year-over-year.
- Novartis AG retained earnings (accumulated deficit) for 2023 were $45.883B, a 21.63% decline from 2022.
- Novartis AG retained earnings (accumulated deficit) for 2022 were $58.544B, a 12.36% decline from 2021.
- Novartis AG retained earnings (accumulated deficit) for 2021 were $66.802B, a 19.85% increase from 2020.